| Cover | Oct. 13, 2021 |
| Cover [Abstract] | |
| Document Type | 8-K/A |
| Amendment Flag | true |
| Amendment Description | This Current Report on Form 8-K/A is being filed as an amendment to the Current Report on Form 8-K filed by InMed Pharmaceuticals Inc. (“InMed” or the “Company”) with the Securities and Exchange Commission (“SEC”) on October 13, 2021. |
| Document Period End Date | Oct. 13, 2021 |
| Entity File Number | 001-39685 |
| Entity Registrant Name | INMED PHARMACEUTICALS INC. |
| Entity Central Index Key | 0001728328 |
| Entity Tax Identification Number | 98-1428279 |
| Entity Incorporation, State or Country Code | A1 |
| Entity Address, Address Line One | Suite 310 - 815 W. Hastings Street |
| Entity Address, City or Town | Vancouver, B.C. |
| Entity Address, Country | CA |
| Entity Address, Postal Zip Code | V6C 1B4 |
| City Area Code | (604) |
| Local Phone Number | 669-7207 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Title of 12(b) Security | Common Shares, no par value |
| Trading Symbol | INM |
| Security Exchange Name | NASDAQ |
| Entity Emerging Growth Company | true |
| Elected Not To Use the Extended Transition Period | false |
